Based on 1 Wall Street analysts offering 12 month price targets for Hangzhou Tigermed Consulting Co., Ltd. Class H in the last 3 months. The average price target is €3.20 with a high forecast of €3.20 and a low forecast of €3.20. The average price target represents a -4.76% change from the last price of €3.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","3":"€3","4":"€4","5":"€5","6":"€6"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.19805434,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€3.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.19805434,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€3.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,3,4,5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2023","6":"Apr<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.06,3.9936964876923073,3.927392975384615,3.861089463076923,3.7947859507692305,3.7284824384615383,3.662178926153846,3.5958754138461537,3.5295719015384615,3.463268389230769,3.396964876923077,3.3306613646153846,3.2643578523076924,{"y":3.19805434,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.06,3.9938461538461536,3.9276923076923076,3.861538461538461,3.795384615384615,3.729230769230769,3.663076923076923,3.596923076923077,3.5307692307692307,3.4646153846153847,3.3984615384615386,3.332307692307692,3.2661538461538466,{"y":3.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.06,3.9936964876923073,3.927392975384615,3.861089463076923,3.7947859507692305,3.7284824384615383,3.662178926153846,3.5958754138461537,3.5295719015384615,3.463268389230769,3.396964876923077,3.3306613646153846,3.2643578523076924,{"y":3.19805434,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.69,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4.83,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4.83,"date":1696118400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5,"date":1701388800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5,"date":1704067200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.63,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.12,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.06,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€3.20

Average Price Target€3.20

Lowest Price Target€3.20

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

xxxxxxxxxxxxxxxxxx

J.P. Morgan

xxxxxxxxxxxxx

Downgraded

11/01/24

xxxxxxxxxxxxx

Unknown Analyst

Not Ranked

Jefferies

€6.13

Buy

82.56%

Upside

Reiterated

10/25/24

Michael Luo CFA

CLSA

€4.71→€7.16

Buy

113.23%

Upside

Reiterated

10/04/24

Hangzhou Tigermed Consulting Co (3347:HK) PT Raised to HK$58.40 at CLSACLSA analyst Michael Luo raised the price target on Hangzhou Tigermed Consulting Co (3347:HK) to HK$58.40 (from HK$38.40) while maintaining a Outperform (2) rating.

Jialin Zhang

Nomura

€3.76→€3.5

Hold

4.28%

Upside

Reiterated

08/29/24

Hangzhou Tigermed Consulting Co (3347:HK) PT Lowered to HK$28.56 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Hangzhou Tigermed Consulting Co (3347:HK) to HK$28.56 (from HK$30.65) while maintaining a Neutral rating.

Chen Chen

UBS

€4.1→€5.67

Buy

68.69%

Upside

Upgraded

06/12/24

UBS Upgrades Hangzhou Tigermed Consulting Co (3347:HK) to BuyUBS analyst Chen Chen upgraded Hangzhou Tigermed Consulting Co (3347:HK) from Neutral to Buy with a price target of HK$46.20 (from HK$33.40).

Linda Shu

HSBC

€9.05→€8.48

Buy

152.30%

Upside

Reiterated

04/10/24

Hangzhou Tigermed Consulting Co (3347:HK) PT Lowered to HK$69.10 at HSBCHSBC analyst Linda Shu lowered the price target on Hangzhou Tigermed Consulting Co (3347:HK) to HK$69.10 (from HK$73.80) while maintaining a Buy rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hangzhou Tigermed Consulting Co., Ltd. Class H

Which Analyst Should I Follow If I Want to Buy DE:5HZ1 and Sell After:

1 Month

xxx

Success Rate

1/4 ratings generated profit

Average Return

-6.08%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -6.08% per trade.

3 Months

xxx

Success Rate

0/4 ratings generated profit

Average Return

-13.93%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -13.93% per trade.

1 Year

Michael Luo CFACLSA

Success Rate

0/4 ratings generated profit

Average Return

-14.12%

reiterated a buy rating 4 months ago

Copying Michael Luo CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -14.12% per trade.

2 Years

xxx

Success Rate

0/4 ratings generated profit

Average Return

-14.12%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -14.12% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

5HZ1 Analyst Recommendation Trends

Rating

Jul 24

Aug 24

Sep 24

Oct 24

Nov 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 5HZ1 has received 2 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 5HZ1 average Analyst price target in the past 3 months is €3.20.

Each month's total comprises the sum of three months' worth of ratings.

5HZ1 Financial Forecast

5HZ1 Earnings Forecast

Next quarter’s earnings estimate for 5HZ1 is €0.02 with a range of -€0.05 to €0.08. The previous quarter’s EPS was €0.05. 5HZ1 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year 5HZ1 has Preformed in-line its overall industry.

5HZ1 Sales Forecast

Next quarter’s sales forecast for 5HZ1 is €234.89M with a range of €190.20M to €279.58M. The previous quarter’s sales results were €228.55M. 5HZ1 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year 5HZ1 has Preformed in-line its overall industry.

5HZ1 Stock Forecast FAQ

What is DE:5HZ1’s average 12-month price target, according to analysts?

Based on analyst ratings, Hangzhou Tigermed Consulting Co., Ltd. Class H’s 12-month average price target is €3.20.

What is DE:5HZ1’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:5HZ1, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Hangzhou Tigermed Consulting Co., Ltd. Class H a Buy, Sell or Hold?

Hangzhou Tigermed Consulting Co., Ltd. Class H has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.

What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s share price target?

The average share price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is €3.20. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €3.20 ,and the lowest forecast is €3.20. The average share price target represents -4.76% Decrease from the current price of €3.36.

What do analysts say about Hangzhou Tigermed Consulting Co., Ltd. Class H?

Hangzhou Tigermed Consulting Co., Ltd. Class H’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Hangzhou Tigermed Consulting Co., Ltd. Class H?

To buy shares of DE:5HZ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Stock Forecast & Price Target

5HZ1 Analyst Ratings

5HZ1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Hangzhou Tigermed Consulting Co., Ltd. Class H

5HZ1 Analyst Recommendation Trends

5HZ1 Financial Forecast

5HZ1 Earnings Forecast

5HZ1 Sales Forecast

5HZ1 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts